Investors are closely watching Eli Lilly & Company (LLY) as the pharmaceutical giant prepares to release its fiscal third-quarter results later this week. Analysts are expecting strong performance driven by the https://zaynasgj552295.liberty-blog.com/36788263/analyzing-eli-lilly-s-q3-results